body
Light Sensitivity
Adverse effectLight Sensitivity is an adverse effect in which exposure to light becomes unusually difficult to tolerate. It may be described as photophobia or sensitivity to light, rather than an improvement in vision.
Light Sensitivity is categorized as a body effect—see its focused overview in one place.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
Red Light Therapy (Photobiomodulation)practiceUnclear
Based on one study. Strongest study: a pooled analysis of several trials.
A 2025 pooled analysis of randomized and non-randomized human studies reported photophobia, or light sensitivity.
Open the Red Light Therapy (Photobiomodulation) page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on1 listedHighest probability
- →PracticesRed Light Therapy (Photobiomodulation)CertaintyLowSourceClinical1 other source
A 2025 pooled analysis of randomized and non-randomized human studies reported photophobia, or light sensitivity.
Who was studied
- People with a condition
Open Red Light Therapy (Photobiomodulation)Study result
Photophobia
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Light Sensitivity is an adverse effect in which exposure to light becomes unusually difficult to tolerate. It may be described as photophobia or sensitivity to light, rather than an improvement in vision. It is listed in connection with interventions including St. John's Wort and Coenzyme Q10.
How interventions help
Interventions associated with Light Sensitivity do not all point in the same direction. Lemon Balm (Melissa) was studied as a short, repeated course rather than as continuous daily use: 330 mg three times daily for 3 days per cycle for 2 cycles. Changes appeared over weeks. The Melissa group mean score decreased from 0.32 to 0.20, compared with a decrease from 0.38 to 0.30 with placebo; the between-group difference was significant only in cycle 2 (P=0.03). This suggests that any improvement may depend on continuing the planned cycles and may not be evident immediately.
Other interventions have been associated with increased sensitivity rather than improvement. St. John's Wort has been linked with sensitivity to light, while photophobia has been reported as an uncommon adverse effect of Coenzyme Q10. These findings describe different types of relationship: one intervention was evaluated for a change in symptom score, whereas the others concern light sensitivity occurring during use.
The studies did not specify the health status of the people studied, so it is not clear from these findings whether the results apply equally across different underlying causes or health conditions. The evidence therefore supports distinguishing between interventions studied for reducing Light Sensitivity and interventions reported in connection with causing or worsening sensitivity, rather than treating all entries as comparable treatment options.
Choosing guidance
These entries are not interchangeable choices for improving Light Sensitivity. Lemon Balm (Melissa) is the only option listed with a defined studied regimen, a defined study period, and an expected onset measured in weeks. It also has human evidence, although the observed difference between Lemon Balm (Melissa) and placebo appeared only in the second cycle. This makes it the most practically interpretable option for someone considering how treatment timing might relate to results, while still leaving uncertainty about how broadly the finding applies because the studied health status was not specified.
St. John's Wort and Coenzyme Q10 are listed as possible causes rather than interventions for improving Light Sensitivity. They therefore may be more relevant when reviewing a new or worsening symptom than when selecting a supplement for benefit. No comparable dosing, duration, or onset information is provided for either one, so their entries cannot be weighed against Lemon Balm (Melissa) on those practical grounds.
The evidence also differs in kind. Lemon Balm (Melissa) has a clinical finding from a randomized controlled trial, while St. John's Wort is supported by clinical evidence summarized in a systematic review, and Coenzyme Q10 is represented by a pharmacology reference. These categories describe different types of support and should not be treated as direct head-to-head comparisons. Overall, Lemon Balm (Melissa) is the only listed option with a studied use pattern and human trial information; the other entries are better considered in the context of possible causes rather than as alternatives for relief.